XML 15 R4.htm IDEA: XBRL DOCUMENT v3.20.2
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($)
shares in Thousands, $ in Thousands
3 Months Ended 9 Months Ended
Sep. 30, 2020
Sep. 30, 2019
Sep. 30, 2020
Sep. 30, 2019
Income Statement [Abstract]        
Product sales, net $ 31,020 $ 30,499 $ 77,712 $ 78,460
Other revenue 1,238 0 1,238 0
Total revenue 32,258 30,499 78,950 78,460
Cost of product sales 9,787 9,324 28,369 26,986
Gross profit 22,471 21,175 50,581 51,474
Research and development 2,913 3,096 9,902 27,174
Selling, general and administrative 16,041 14,982 50,596 44,761
Total operating expenses 18,954 18,078 60,498 71,935
Income (loss) from operations 3,517 3,097 (9,917) (20,461)
Other income (expense):        
Interest income 121 385 574 1,293
Other income (expense) (2) (2) (5) (6)
Interest expense (18) (10) (8) 8
Total other income 101 373 561 1,295
Net income (loss) $ 3,618 $ 3,470 $ (9,356) $ (19,166)
Net (loss) income per share (Basic) (in USD per share) $ 0.08 $ 0.08 $ (0.21) $ (0.44)
Weighted average number of common shares outstanding (Basic) (in shares) 45,272 44,251 45,112 43,979
Net (loss) income per share (Diluted) (in USD per share) $ 0.08 $ 0.07 $ (0.21) $ (0.44)
Weighted average number of common shares outstanding (Diluted) (in shares) 47,314 46,667 45,112 43,979
Revenue, Product and Service [Extensible List]     us-gaap:ProductMember  
Cost, Product and Service [Extensible List]     us-gaap:ProductMember